These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12811110)

  • 1. Let evidence be the arbiter.
    Lindberg MC
    Healthc Pap; 2002; 3(1):43-6; discussion 87-94. PubMed ID: 12811110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug policy: making effective drugs available without bankrupting the healthcare system.
    Laupacis A; Anderson G; O'Brien B
    Healthc Pap; 2002; 3(1):12-30. PubMed ID: 12811107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting the cat back in the bag: reforming the way provinces manage drug expenditures to make them manageable.
    Levy AR; Gagnon YM
    Healthc Pap; 2002; 3(1):32-7; discussion 87-94. PubMed ID: 12811108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug policy: the challenge is to overcome fragmentation.
    McFarlance A
    Healthc Pap; 2002; 3(1):38-42: discussion 87-94. PubMed ID: 12811109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence, prescribing and the Drug Tariff.
    Stephen-Haynes J
    Br J Community Nurs; 2006 Sep; 11(9):S3-4. PubMed ID: 17077755
    [No Abstract]   [Full Text] [Related]  

  • 6. More of the same is not enough.
    Willison DJ
    Healthc Pap; 2002; 3(1):47-55; discussion 87-94. PubMed ID: 12811111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug policy: an oxymoron?
    Gray J
    Healthc Pap; 2002; 3(1):56-62; discussion 87-94. PubMed ID: 12811112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Our advice? Get a budget!
    Brougham M; Metcalfe S; McNee W
    Healthc Pap; 2002; 3(1):83-5; discussion 87-94. PubMed ID: 12811116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national drug agency.
    West R; Borden EK; Collet JP; Rawson NS; Tonks RS
    CMAJ; 2003 Apr; 168(8):962-3. PubMed ID: 12695372
    [No Abstract]   [Full Text] [Related]  

  • 11. We need Romanow's National Drug Agency.
    CMAJ; 2003 Feb; 168(3):249, 251. PubMed ID: 12566321
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing healthcare costs within an integrated framework.
    Fernandes R
    Healthc Pap; 2002; 3(1):70-6; discussion 87-94. PubMed ID: 12811114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-death experiences delivered to your home by your friends on the Internet.
    Lanier WL
    Mayo Clin Proc; 2004 Aug; 79(8):979-82. PubMed ID: 15301323
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of medication use in Scotland.
    Covvey JR; McTaggart S; Bishop I
    Am J Health Syst Pharm; 2010 Aug; 67(16):1378-82. PubMed ID: 20689130
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs, health and the economy: investment, innovation, outcomes, growth.
    Montague T; Cavanaugh S; Skilton K; Szabo G; Sidel J; Gregoire JP
    Healthc Pap; 2002; 3(1):63-9; discussion 87-94. PubMed ID: 12811113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HEALTH TECHNOLOGY ASSESSMENT IN SERBIA.
    Atanasijevic D; Zah V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):384-389. PubMed ID: 28662733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hard decisions about fundamental values.
    Laupacis A
    Healthc Pap; 2004; 4(3):60-6; discussion 68-72. PubMed ID: 15114071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness approach to drug subsidy and pricing in Australia.
    Birkett DJ; Mitchell AS; McManus P
    Health Aff (Millwood); 2001; 20(3):104-14. PubMed ID: 11585158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the AMCP Format for Formulary Submissions.
    Watkins JB; Sullivan SD; Sampsel E; Fullerton DSP; Graff JS; Fry RN; Lee J; Tam IM; Avey SG
    J Manag Care Spec Pharm; 2020 Jun; 26(6):696-700. PubMed ID: 32463780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.